Literature DB >> 27034564

Serendipitous discovery of peritoneal mesothelioma.

Adam Jaster1, Jason Wachsmann1.   

Abstract

We present the case of a 64-year-old patient with a history of Birt-Hogg-Dube syndrome, polycystic kidney disease treated with renal transplantation in May 2013, and multiple types of skin cancers, including malignant melanoma. He presented for lymphoscintigraphy for sentinel lymph node identification of the melanoma. Subsequent biopsy of the right axillary sentinel lymph node yielded a diagnosis of epithelial type malignant mesothelioma without a known primary tumor. Follow-up positron emission tomography with 2-deoxy-2-(fluorine-18)fluoro-D-glucose integrated with computed tomography (F-18 FDG PET/CT) demonstrated several suspicious hypermetabolic abdominal masses that were later confirmed to be epithelial-type mesothelioma via percutaneous biopsy.

Entities:  

Year:  2016        PMID: 27034564      PMCID: PMC4790566          DOI: 10.1080/08998280.2016.11929410

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.

Authors:  Qi Cao; Minh Lu; Jonathon Heath; Petr F Hausner; H Richard Alexander; Vasken Dilsizian; Wengen Chen
Journal:  Clin Nucl Med       Date:  2012-05       Impact factor: 7.794

2.  Scrotal peritoneal mesothelioma on PET/CT.

Authors:  Salih Ozguven; Mustafa Aras; Fuat Dede; Tunc Ones; Halil Turgut Turoglu
Journal:  Clin Nucl Med       Date:  2014-12       Impact factor: 7.794

Review 3.  Malignant pleural mesothelioma: the standard of care and challenges for future management.

Authors:  Jan P van Meerbeeck; Arnaud Scherpereel; Veerle F Surmont; Paul Baas
Journal:  Crit Rev Oncol Hematol       Date:  2010-05-13       Impact factor: 6.312

Review 4.  Peritoneal mesothelioma: a review.

Authors:  Alessio Bridda; Ilaria Padoan; Roberto Mencarelli; Mauro Frego
Journal:  MedGenMed       Date:  2007-05-10

5.  A case of malignant peritoneal mesothelioma revealed with limitation of PET-CT in the diagnosis of thoracic metastasis.

Authors:  Takeshi Saraya; Takuma Yokoyama; Haruyuki Ishii; Yasutaka Tanaka; Naoki Tsujimoto; Yukari Ogawa; Erei Sohara; Akira Nakajima; Toshiya Inui; Hiraoka Sayuki; Masachika Fujiwara; Teruaki Oka; Riken Kawachi; Tomoyuki Goya; Hajime Takizawa; Hajime Goto
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

6.  Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.

Authors:  Anna Domènech-Vilardell; Michael J Rasiej; Robert N Taub; Masanori Ichise
Journal:  Q J Nucl Med Mol Imaging       Date:  2014-04-14       Impact factor: 2.346

Review 7.  Advances in the management of peritoneal mesothelioma.

Authors:  Ali Raza; Wei-Ching Huang; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

8.  PET/CT demonstration and monitoring of thoracic and abdominal wall mesothelioma.

Authors:  Ba D Nguyen
Journal:  Clin Nucl Med       Date:  2014-01       Impact factor: 7.794

  8 in total
  2 in total

1.  Melanoma in a patient with previously unrecognized Birt-Hogg-Dubé syndrome.

Authors:  Somaira Nowsheen; Jennifer L Hand; Lawrence E Gibson; Rokea A El-Azhary
Journal:  JAAD Case Rep       Date:  2019-10-24

2.  Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.

Authors:  Sounak Gupta; Lori A Erickson; Christine M Lohse; Wei Shen; Beth A Pitel; Shannon M Knight; Kevin C Halling; Loren Herrera-Hernandez; Stephen A Boorjian; R Houston Thompson; Bradley C Leibovich; Rafael E Jimenez; John C Cheville
Journal:  JAMA Netw Open       Date:  2021-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.